169 related articles for article (PubMed ID: 2161992)
1. Relation of Na+, K(+)-ATPase to delayed motor nerve conduction velocity: effect of aldose reductase inhibitor, ADN-138, on Na+, K(+)-ATPase activity.
Hirata Y; Okada K
Metabolism; 1990 Jun; 39(6):563-7. PubMed ID: 2161992
[TBL] [Abstract][Full Text] [Related]
2. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
Hirata Y; Fujimori S; Okada K
Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
[TBL] [Abstract][Full Text] [Related]
4. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.
Yasuda H; Sonobe M; Hisanaga T; Kawabata T; Maeda K; Kikkawa R; Shigeta Y
Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179
[TBL] [Abstract][Full Text] [Related]
5. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
Greene DA; Mackway AM
Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804
[TBL] [Abstract][Full Text] [Related]
6. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
Gillon KR; Hawthorne JN; Tomlinson DR
Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
[TBL] [Abstract][Full Text] [Related]
7. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.
Raccah D; Coste T; Cameron NE; Dufayet D; Vague P; Hohman TC
J Diabetes Complications; 1998; 12(3):154-62. PubMed ID: 9618071
[TBL] [Abstract][Full Text] [Related]
8. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
Mayer JH; Tomlinson DR
Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
[TBL] [Abstract][Full Text] [Related]
9. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
Yeh LA; Rafford CE; Goddu KJ; Ashton MA; Beyer TA; Hutson NJ
Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260
[TBL] [Abstract][Full Text] [Related]
10. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
Cameron NE; Cotter MA; Robertson S
Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy.
Calcutt NA; Tomlinson DR; Biswas S
Diabetes; 1990 Jun; 39(6):663-6. PubMed ID: 2161366
[TBL] [Abstract][Full Text] [Related]
12. Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats.
Carrington AL; Ettlinger CB; Calcutt NA; Tomlinson DR
Diabetologia; 1991 Jun; 34(6):397-401. PubMed ID: 1653157
[TBL] [Abstract][Full Text] [Related]
13. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors.
Sredy J; Flam BR; Sawicki DR
Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
Greene DA; Lattimer SA
Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175
[TBL] [Abstract][Full Text] [Related]
15. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H
Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
[TBL] [Abstract][Full Text] [Related]
16. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.
Greene DA; Chakrabarti S; Lattimer SA; Sima AA
J Clin Invest; 1987 May; 79(5):1479-85. PubMed ID: 3033025
[TBL] [Abstract][Full Text] [Related]
17. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation.
Yorek MA; Wiese TJ; Davidson EP; Dunlap JA; Stefani MR; Conner CE; Lattimer SA; Kamijo M; Greene DA; Sima AA
Diabetes; 1993 Oct; 42(10):1401-6. PubMed ID: 8397126
[TBL] [Abstract][Full Text] [Related]
18. Glomerular Na+-K+-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition.
Cohen MP; Klepser H
Diabetes; 1988 May; 37(5):558-62. PubMed ID: 2834250
[TBL] [Abstract][Full Text] [Related]
19. Reduced Na+/K+ adenosine triphosphatase activity and motor nerve conduction velocity in L-fucose-fed rats is reversible after dietary normalization.
Yorek MA; Wiese TJ; Davidson EP; Dunlap JA; Conner CE
Metabolism; 1996 Feb; 45(2):229-34. PubMed ID: 8596495
[TBL] [Abstract][Full Text] [Related]
20. Effect of myo-inositol on renal Na-K-ATPase in experimental diabetes.
Cohen RA; MacGregor LC; Spokes KC; Silva P; Epstein FH
Metabolism; 1990 Oct; 39(10):1026-32. PubMed ID: 2170818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
